In a settlement with the Financial Industry Regulatory Authority (FINRA), UBS Financial Services Inc. (UBS FSI) agreed to a $1.1 million fine and a censure following a six-year span of inaccurate trade data submissions that affected more than 4.4 million transactions.
In a move against one of Scandinavia’s banking giants, Norway's Finanstilsynet has fined Danske Bank approximately $4.4 million (NOK 50 million) for market manipulation tied to a high-stakes government bond issuance in early 2023. The penalty underscores the seriousness of tampering with market benchmarks, particularly when taxpayer dollars are on the line.
In a decision that demonstrates the deepening philosophical divide over regulation and the future of artificial intelligence (AI), President Donald Trump has overturned a key executive order issued by former President Joe Biden. The order, signed in 2023, sought to address AI risks head-on by mandating safety tests for high-risk AI systems before they hit the market.
In a move as timely as a life-saving intervention, the European Union Agency for Cybersecurity, ENISA, has set its sights on strengthening the digital defenses of Europe's healthcare systems. With hospitals and healthcare providers increasingly targeted by cyberattacks, the European Commission's proposed Action Plan for Healthcare Cybersecurity couldn’t be more urgent. ENISA has pledged to collaborate with Member States, healthcare providers, and the wider cybersecurity community to address this pressing challenge.
Germany has thrown its hat into the sustainability ring—though not quite in the way Brussels might have hoped. Just weeks before a pivotal federal election, and amid the collapse of its coalition government, Berlin is calling for a major rethink of the EU’s Corporate Sustainability Reporting Directive (CSRD). The proposals aim to give smaller companies a two-year reprieve from sustainability reporting requirements and eliminate sector-specific obligations entirely.
The opioid crisis has left scars on communities across America, claiming hundreds of thousands of lives over the past two decades. While pharmaceutical manufacturers and rogue prescribers often dominate the headlines, pharmacy chains have increasingly found themselves in the DOJ’s crosshairs for their alleged role in this public health disaster. Now, Walgreens Boots Alliance, one of the nation’s largest pharmacy chains, faces a civil lawsuit from the Justice Department for allegedly fueling the epidemic by dispensing millions of unlawful prescriptions.
Every few years, the European Banking Authority (EBA) holds up a mirror to the banking sector, asking a straightforward yet critical question: “What if?” The 2025 EU-wide stress test is no different—but this time, the stakes feel particularly high.